메뉴 건너뛰기




Volumn 21, Issue 12, 2015, Pages 2660-2662

CD38-Targeted immunochemotherapy in refractory multiple myeloma: A new horizon

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CARFILZOMIB; CD38 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DARATUMUMAB; DEXAMETHASONE; LENALIDOMIDE; PANOBINOSTAT; POMALIDOMIDE; THALIDOMIDE;

EID: 84930319546     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-3190     Document Type: Article
Times cited : (41)

References (14)
  • 1
    • 84941342711 scopus 로고    scopus 로고
    • Preclinical evidence for the therapeutic potential of cd38-targeted immuno-chemotherapy in multiple myeloma patients refractory to lenalidomide and bortezomib
    • Nijhof IS, Groen RWJ, Noort WA, van Kessel B, de Jong-Korlaar R, Bakker J, et al. Preclinical evidence for the therapeutic potential of CD38-targeted immuno-chemotherapy in multiple myeloma patients refractory to lenalidomide and bortezomib. Clin Cancer Res 2015;21:2802-10.
    • (2015) Clin Cancer Res , vol.21 , pp. 2802-2810
    • Nijhof, I.S.1    Groen, R.W.J.2    Noort, W.A.3    Van Kessel, B.4    De Jong-Korlaar, R.5    Bakker, J.6
  • 2
    • 1642348370 scopus 로고    scopus 로고
    • Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma
    • Lin P, Owens R, Tricot G, Wilson CS. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004;121: 482-8.
    • (2004) Am J Clin Pathol , vol.121 , pp. 482-488
    • Lin, P.1    Owens, R.2    Tricot, G.3    Wilson, C.S.4
  • 4
    • 0029909008 scopus 로고    scopus 로고
    • Human cd38, a cell-surface protein with multiple functions
    • Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996;10:1408-17.
    • (1996) FASEB J , vol.10 , pp. 1408-1417
    • Mehta, K.1    Shahid, U.2    Malavasi, F.3
  • 5
    • 0028930578 scopus 로고
    • Evaluation of cd38 as target for immunotherapy in multiple myeloma
    • Vooijs WC, Schuurman HJ, Bast EJ, de Gast GC. Evaluation of CD38 as target for immunotherapy in multiple myeloma. Blood 1995;85:2282-4.
    • (1995) Blood , vol.85 , pp. 2282-2284
    • Vooijs, W.C.1    Schuurman, H.J.2    Bast, E.J.3    De Gast, G.C.4
  • 6
    • 50349083286 scopus 로고    scopus 로고
    • Evolution and function of the adp ribosyl cyclase/cd38 gene family in physiology and pathology
    • Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008;88:841-86.
    • (2008) Physiol Rev , vol.88 , pp. 841-886
    • Malavasi, F.1    Deaglio, S.2    Funaro, A.3    Ferrero, E.4    Horenstein, A.L.5    Ortolan, E.6
  • 7
    • 0035177850 scopus 로고    scopus 로고
    • Human cd38: A (r)evolutionary story of enzymes and receptors
    • Deaglio S, Mehta K, Malavasi F. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res 2001;25:1-12.
    • (2001) Leuk Res , vol.25 , pp. 1-12
    • Deaglio, S.1    Mehta, K.2    Malavasi, F.3
  • 11
    • 34547106018 scopus 로고    scopus 로고
    • Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
    • Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 2007;7:585-98.
    • (2007) Nat Rev Cancer , vol.7 , pp. 585-598
    • Hideshima, T.1    Mitsiades, C.2    Tonon, G.3    Richardson, P.G.4    Anderson, K.C.5
  • 13
    • 84941970153 scopus 로고    scopus 로고
    • Daratumumab a cd38 monoclonal antibody in patients with multiple myeloma-data from a dose-escalation phase i/II study [abstract]
    • Dec 8-11; Atlanta GA. Washington (DC): American Society of Hematology. Abstract nr 73
    • Plesner T, Lokhorst H, Gimsing P, Nahi H, Richardson PG. Daratumumab, a CD38 monoclonal antibody in patients with multiple myeloma-data from a dose-escalation phase I/II study [abstract]. In: Proceedings of the 54th ASH Annual Meeting and Exposition; 2012 Dec 8-11; Atlanta, GA. Washington (DC): American Society of Hematology. Abstract nr 73.
    • (2012) Proceedings of the 54th ASH Annual Meeting and Exposition
    • Plesner, T.1    Lokhorst, H.2    Gimsing, P.3    Nahi, H.4    Richardson, P.G.5
  • 14
    • 84939463881 scopus 로고    scopus 로고
    • Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed refractory multiple myeloma [abstract]
    • Dec 6-9; San Francisco CA. Washington (DC): American Society of Hematology. Abstract nr 84
    • Plesner T, ArkenauH-T, Lokhorst HM, Gimsing P, Krejcik J, Lemech C, et al. Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma [abstract]. In: Proceedings of the 56th ASH Annual Meeting and Exposition; 2014 Dec 6-9; San Francisco, CA. Washington (DC): American Society of Hematology. Abstract nr 84.
    • (2014) Proceedings of the 56th ASH Annual Meeting and Exposition
    • Plesner, T.1    Arkenau, H.-T.2    Lokhorst, H.M.3    Gimsing, P.4    Krejcik, J.5    Lemech, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.